TABLE 2.
Comparative costs for malaria treatment of West African refugees by strategy, 1998–2004*
| Strategy | Artemether-lumefantrine presumptive treatment | Observed U.S. malaria cases | Expected U.S. malaria cases |
|---|---|---|---|
| Presumptive overseas Pre-departure treatment | All† | Actual | None† |
| Refugees treated | 2,332 | 51 | 191‡ |
| Cost per treatment course | $14.40 | $1,729.50 | $1,729.50 |
| Total treatment cost | $33,580 | $88.205 | $330,335 |
| Relative treatment cost | 38% | 100% | 375% |
| Malaria prevalence: cost-benefit policy breakpoint§ | 1.0% | NA | NA |
NA = not applicable.
Theoretical.
If overseas presumptive therapy had not started in 1999, an expected 191 cases of malaria would have occurred among 2,332 refugees. This is derived from the preimplementation refugee malaria rate of 8.2%.
Prevalence of malaria above which it is more cost-beneficial to use an overseas presumptive treatment strategy.